Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation

Liver Transplantation

Volumn 9, Issue 8, 2003, Pages 851-856

  Rinella, Mary E ^a   McCarthy, Richard ^a   Thakrar, Kiran ^a   Finn, John Paul ^a   Rao, Sambasiva M ^a   Koffron, Alan J ^a   Abecassis, Michael ^a   Blei, Andres T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

EID: 0042563332     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50153     Document Type: Article

References (28)

1. Garcia Urena MA, Colina Ruiz-Delgado F, Moreno Gonzalez E, Jimenez Romero C, Garcia Garcia I, Loinzaz Segurola C, et al. Hepatic steatosis in liver transplant donors: Common feature of donor population? World J Surg 1998;22:837-844.
2. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-1251.
3. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffman RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991;51:157-163.
4. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffman RM, et al. Risk factors for primary dysfunction after liver transplantation - A multivariate analysis. Transplantation 1993;55:807-813.
5. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292-298.
6. Rinella ME, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001;7:409-414.
7. Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, et al. Fatty infiltration of the liver: Quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 1991;156:307-312.
8. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masotti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997;27:108-113.
9. Pamilo M, Sotaniemi EA, Suramo I, Lahde S, Arranto AJ. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol 1983;18: 743-747.
10. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-750.
11. Mortele KJ, Ros PR. MR imaging in chronic hepatitis and cirrhosis. Semin Ultrasound CT MR 2002;23:79-100.
12. Lee SG, Park KM, Lee YJ, Hwang S, Choi DR, Ahn CS, et al. 157 adult-to-adult living donor liver transplantation. Transplant Proc 2001;33:1323-1325.
13. Cheng YF, Chen CL, Huang TL, Chen TY, Lee TY, Chen YS, et al. Single imaging modality evaluation of living donors in liver transplantation: Magnetic resonance imaging. Transplantation 2001;72:1527-1533.
14. Cheng YF, Chen CL, Lai CY, Chen TY, Huang TL, Lee TY, et al. Assessment of donor fatty livers for liver transplantation. Transplantation 2001;71:1221-1225.
15. Rofsky NM, Fleishaker H. CT and MRI of diffuse liver disease. Semin Ultrasound CT MR 1995;16:16-33.
16. Outwater EK, Blasbalg R, Siegelman ES, Vala M. Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: Techniques and diagnostic importance. Radiographics 1998;18:1465-1480.
17. Sohn J, Siegelman E, Osiason A. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 2001;176:471-474.
18. Marks SJ, Moore NR, Ryley NG, Clark ME, Pointon JJ, Strauss BJ, et al. Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM. Int J Obes Relat Metab Disord 1997;21:274-279.
19. Couinaud C. [Definition of hepatic anatomical regions and their value during hepatectomy (author's translation)]. Chirurgie 1980;106:103-108.
20. Kreft BP, Tanimoto A, Baba Y, Zhao L, Chen J, Middleton MS, et al. Diagnosis of fatty liver with MR imaging. J Magn Reson Imaging 1992;2:463-471.
21. Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Makita O, Kadota M, et al. Adrenal masses: Quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology 2001;218:642-646.
22. Wenker JC, Baker MK, Ellis JH, Glant MD. Focal fatty infiltration of the liver: Demonstration by magnetic resonance imaging. AJR Am J Roentgenol 1984;143:573-574.
23. Yates CK, Streight RA. Focal fatty infiltration of the liver simulating metastatic disease. Radiology 1986;159:83-84.
24. Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000;135:336-340.
25. Rinella ME, Abecassis MM. Liver biopsy in living donors. Liver Transpl 2002;8:1123-1125.
26. Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002;8:1114-1122.
27. Tode S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47:903-905.
28. Selzner M, Rudiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000;32:1280-1288.